South Plains Financial (NASDAQ:SPFI) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.49 by 79.59 percent. This is a 18.92 percent increase over earnings of $0.74 per share from the same period last year.
Merck’s Lead Cancer Drug Meets Primary Goal In Certain Type Of Lung Cancer Patients
Merck & Co Inc (NYSE: MRK) reported topline data from the Phase 3 KEYNOTE-671 trial investigating Keytruda, Merck's anti-PD-1 therapy, as a perioperative treatment regimen for patients with resectable stage II, IIIA or IIIB (T3-4N2)
